Probi Past Earnings Performance

Past criteria checks 1/6

Probi's earnings have been declining at an average annual rate of -32.7%, while the Biotechs industry saw earnings growing at 22.1% annually. Revenues have been declining at an average rate of 1.6% per year. Probi's return on equity is 0.8%, and it has net margins of 1.7%.

Key information

-32.7%

Earnings growth rate

-32.7%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate-1.6%
Return on equity0.8%
Net Margin1.7%
Next Earnings Update28 Jan 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Probi makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:PBBI.F Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246301117036
30 Jun 246431417037
31 Mar 24608-117437
31 Dec 236281717236
30 Sep 236161417639
30 Jun 236052017438
31 Mar 236354616839
31 Dec 226184116738
30 Sep 226447315936
30 Jun 226587915538
31 Mar 226427514737
31 Dec 216588314337
30 Sep 216737914039
30 Jun 217099314437
31 Mar 2173110514437
31 Dec 207179315036
30 Sep 206999714933
30 Jun 206458514432
31 Mar 206468815333
31 Dec 196268615131
30 Sep 196238415430
30 Jun 196509015731
31 Mar 196238115031
31 Dec 186047614733
30 Sep 185615313935
30 Jun 185253413934
31 Mar 185442913935
31 Dec 176126913837
30 Sep 176879814741
30 Jun 1764311713841
31 Mar 1754411812240
31 Dec 1644310210337
30 Sep 16286745354
30 Jun 16248604948
31 Mar 16234545338
31 Dec 15216495731
30 Sep 1522052820
30 Jun 1520546760
31 Mar 1517839670
31 Dec 1413522600
30 Sep 1412219580
30 Jun 1410916560
31 Mar 1410415550
31 Dec 1310415550

Quality Earnings: PBBI.F has high quality earnings.

Growing Profit Margin: PBBI.F's current net profit margins (1.7%) are lower than last year (2.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PBBI.F's earnings have declined by 32.7% per year over the past 5 years.

Accelerating Growth: PBBI.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: PBBI.F had negative earnings growth (-20.4%) over the past year, making it difficult to compare to the Biotechs industry average (16.6%).


Return on Equity

High ROE: PBBI.F's Return on Equity (0.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 18:48
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Probi AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jakob LembkeABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored
Hans MählerHandelsbanken Capital Markets